APO RESEARCH · REPORT
Medical Cold Plasma
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Product & engineering
Understand the product.
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.
Selected research
Industry Growth & Trends
Global Medical Cold Plasma Industry Growth and Trends Forecast to 2032
Market perspective
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.
The global Medical Cold Plasma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
The North America market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
The Asia Pacific market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Cold Plasma include Apyx Medical, Terraplasma Medical, Wacker Chemie, Neoplas Tools, ADTEC Plasma Technology, Plasmatreat GmbH, Relyon Plasma GmbH, Cinogy GmbH and Plasma Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Medical Cold Plasma market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Medical Cold Plasma market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Cold Plasma market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Cold Plasma.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Medical Cold Plasma market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Medical Cold Plasma Market by Company
Apyx Medical
Terraplasma Medical
Wacker Chemie
Neoplas Tools
ADTEC Plasma Technology
Plasmatreat GmbH
Relyon Plasma GmbH
Cinogy GmbH
Plasma Bioscience
PlasmaMed
Nova Plasma
Medical Cold Plasma Segment by Type
Microwave Plasma
Radio Frequency Plasma
Direct Current Plasma
Medical Cold Plasma Segment by Application
Sterilization and Disinfection
Coagulation and Hemostasis
Dental Applications
Wound Healing
Dermatology Treatment
Beauty and Skin Care
Tumor Treatment
Transfection and Drug Delivery
Material Surface Modification
Medical Cold Plasma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Cold Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Cold Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Cold Plasma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Cold Plasma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Medical Cold Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microwave Plasma
- Radio Frequency Plasma
- Direct Current Plasma
Applications
- Sterilization and Disinfection
- Coagulation and Hemostasis
- Dental Applications
- Wound Healing
- Dermatology Treatment
- Beauty and Skin Care
- Tumor Treatment
- Transfection and Drug Delivery
- Material Surface Modification
Companies covered
- Apyx Medical
- Terraplasma Medical
- Wacker Chemie
- Neoplas Tools
- ADTEC Plasma Technology
- Plasmatreat GmbH
- Relyon Plasma GmbH
- Cinogy GmbH
- Plasma Bioscience
- PlasmaMed
- Nova Plasma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Medical Cold Plasma Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Medical Cold Plasma Sales Estimates and Forecasts (2021-2032)
- 1.3 Medical Cold Plasma Market by Type
- 1.3.1 Microwave Plasma
- 1.3.2 Radio Frequency Plasma
- 1.3.3 Direct Current Plasma
- 1.4 Global Medical Cold Plasma Market Size by Type
- 1.4.1 Global Medical Cold Plasma Market Size Overview by Type (2021-2032)
- 1.4.2 Global Medical Cold Plasma Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Medical Cold Plasma Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Medical Cold Plasma Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Medical Cold Plasma Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Medical Cold Plasma Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Medical Cold Plasma Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Medical Cold Plasma Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Medical Cold Plasma Industry Trends
- 2.2 Medical Cold Plasma Industry Drivers
- 2.3 Medical Cold Plasma Industry Opportunities and Challenges
- 2.4 Medical Cold Plasma Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Medical Cold Plasma Revenue (2021-2026)
- 3.2 Global Top Players by Medical Cold Plasma Sales (2021-2026)
- 3.3 Global Top Players by Medical Cold Plasma Price (2021-2026)
- 3.4 Global Medical Cold Plasma Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Cold Plasma Major Company Production Sites & Headquarters
- 3.6 Global Medical Cold Plasma Company, Product Type & Application
- 3.7 Global Medical Cold Plasma Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Cold Plasma Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Cold Plasma Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Cold Plasma Tier 1, Tier 2, and Tier 3
4 Medical Cold Plasma Regional Status and Outlook
- 4.1 Global Medical Cold Plasma Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Medical Cold Plasma Historic Market Size by Region
- 4.2.1 Global Medical Cold Plasma Sales in Volume by Region (2021-2026)
- 4.2.2 Global Medical Cold Plasma Sales in Value by Region (2021-2026)
- 4.2.3 Global Medical Cold Plasma Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Medical Cold Plasma Forecasted Market Size by Region
- 4.3.1 Global Medical Cold Plasma Sales in Volume by Region (2027-2032)
- 4.3.2 Global Medical Cold Plasma Sales in Value by Region (2027-2032)
- 4.3.3 Global Medical Cold Plasma Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Cold Plasma by Application
- 5.1 Medical Cold Plasma Market by Application
- 5.1.1 Sterilization and Disinfection
- 5.1.2 Coagulation and Hemostasis
- 5.1.3 Dental Applications
- 5.1.4 Wound Healing
- 5.1.5 Dermatology Treatment
- 5.1.6 Beauty and Skin Care
- 5.1.7 Tumor Treatment
- 5.1.8 Transfection and Drug Delivery
- 5.1.9 Material Surface Modification
- 5.2 Global Medical Cold Plasma Market Size by Application
- 5.2.1 Global Medical Cold Plasma Market Size Overview by Application (2021-2032)
- 5.2.2 Global Medical Cold Plasma Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Medical Cold Plasma Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Medical Cold Plasma Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Medical Cold Plasma Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Medical Cold Plasma Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Medical Cold Plasma Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Medical Cold Plasma Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Apyx Medical
- 6.1.1 Apyx Medical Company Information
- 6.1.2 Apyx Medical Business Overview
- 6.1.3 Apyx Medical Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Apyx Medical Medical Cold Plasma Product Portfolio
- 6.1.5 Apyx Medical Recent Developments
- 6.2 Terraplasma Medical
- 6.2.1 Terraplasma Medical Company Information
- 6.2.2 Terraplasma Medical Business Overview
- 6.2.3 Terraplasma Medical Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Terraplasma Medical Medical Cold Plasma Product Portfolio
- 6.2.5 Terraplasma Medical Recent Developments
- 6.3 Wacker Chemie
- 6.3.1 Wacker Chemie Company Information
- 6.3.2 Wacker Chemie Business Overview
- 6.3.3 Wacker Chemie Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Wacker Chemie Medical Cold Plasma Product Portfolio
- 6.3.5 Wacker Chemie Recent Developments
- 6.4 Neoplas Tools
- 6.4.1 Neoplas Tools Company Information
- 6.4.2 Neoplas Tools Business Overview
- 6.4.3 Neoplas Tools Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Neoplas Tools Medical Cold Plasma Product Portfolio
- 6.4.5 Neoplas Tools Recent Developments
- 6.5 ADTEC Plasma Technology
- 6.5.1 ADTEC Plasma Technology Company Information
- 6.5.2 ADTEC Plasma Technology Business Overview
- 6.5.3 ADTEC Plasma Technology Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 ADTEC Plasma Technology Medical Cold Plasma Product Portfolio
- 6.5.5 ADTEC Plasma Technology Recent Developments
- 6.6 Plasmatreat GmbH
- 6.6.1 Plasmatreat GmbH Company Information
- 6.6.2 Plasmatreat GmbH Business Overview
- 6.6.3 Plasmatreat GmbH Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Plasmatreat GmbH Medical Cold Plasma Product Portfolio
- 6.6.5 Plasmatreat GmbH Recent Developments
- 6.7 Relyon Plasma GmbH
- 6.7.1 Relyon Plasma GmbH Company Information
- 6.7.2 Relyon Plasma GmbH Business Overview
- 6.7.3 Relyon Plasma GmbH Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Relyon Plasma GmbH Medical Cold Plasma Product Portfolio
- 6.7.5 Relyon Plasma GmbH Recent Developments
- 6.8 Cinogy GmbH
- 6.8.1 Cinogy GmbH Company Information
- 6.8.2 Cinogy GmbH Business Overview
- 6.8.3 Cinogy GmbH Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Cinogy GmbH Medical Cold Plasma Product Portfolio
- 6.8.5 Cinogy GmbH Recent Developments
- 6.9 Plasma Bioscience
- 6.9.1 Plasma Bioscience Company Information
- 6.9.2 Plasma Bioscience Business Overview
- 6.9.3 Plasma Bioscience Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Plasma Bioscience Medical Cold Plasma Product Portfolio
- 6.9.5 Plasma Bioscience Recent Developments
- 6.10 PlasmaMed
- 6.10.1 PlasmaMed Company Information
- 6.10.2 PlasmaMed Business Overview
- 6.10.3 PlasmaMed Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 PlasmaMed Medical Cold Plasma Product Portfolio
- 6.10.5 PlasmaMed Recent Developments
- 6.11 Nova Plasma
- 6.11.1 Nova Plasma Company Information
- 6.11.2 Nova Plasma Business Overview
- 6.11.3 Nova Plasma Medical Cold Plasma Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Nova Plasma Medical Cold Plasma Product Portfolio
- 6.11.5 Nova Plasma Recent Developments
7 North America by Country
- 7.1 North America Medical Cold Plasma Sales by Country
- 7.1.1 North America Medical Cold Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Medical Cold Plasma Sales by Country (2021-2026)
- 7.1.3 North America Medical Cold Plasma Sales Forecast by Country (2027-2032)
- 7.2 North America Medical Cold Plasma Market Size by Country
- 7.2.1 North America Medical Cold Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Medical Cold Plasma Market Size by Country (2021-2026)
- 7.2.3 North America Medical Cold Plasma Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Medical Cold Plasma Sales by Country
- 8.1.1 Europe Medical Cold Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Medical Cold Plasma Sales by Country (2021-2026)
- 8.1.3 Europe Medical Cold Plasma Sales Forecast by Country (2027-2032)
- 8.2 Europe Medical Cold Plasma Market Size by Country
- 8.2.1 Europe Medical Cold Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Medical Cold Plasma Market Size by Country (2021-2026)
- 8.2.3 Europe Medical Cold Plasma Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Medical Cold Plasma Sales by Country
- 9.1.1 Asia-Pacific Medical Cold Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Medical Cold Plasma Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Medical Cold Plasma Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Medical Cold Plasma Market Size by Country
- 9.2.1 Asia-Pacific Medical Cold Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Medical Cold Plasma Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Medical Cold Plasma Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Medical Cold Plasma Sales by Country
- 10.1.1 South America Medical Cold Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Medical Cold Plasma Sales by Country (2021-2026)
- 10.1.3 South America Medical Cold Plasma Sales Forecast by Country (2027-2032)
- 10.2 South America Medical Cold Plasma Market Size by Country
- 10.2.1 South America Medical Cold Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Medical Cold Plasma Market Size by Country (2021-2026)
- 10.2.3 South America Medical Cold Plasma Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Medical Cold Plasma Sales by Country
- 11.1.1 Middle East and Africa Medical Cold Plasma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Medical Cold Plasma Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Medical Cold Plasma Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Medical Cold Plasma Market Size by Country
- 11.2.1 Middle East and Africa Medical Cold Plasma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Medical Cold Plasma Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Medical Cold Plasma Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Medical Cold Plasma Value Chain Analysis
- 12.1.1 Medical Cold Plasma Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Medical Cold Plasma Production Mode & Process
- 12.2 Medical Cold Plasma Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Medical Cold Plasma Distributors
- 12.2.3 Medical Cold Plasma Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst